Laurence W. Lytton 13D and 13G filings for SUNESIS PHARMACEUTICALS INC CO:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-01-04 12:35 pm Purchase |
2020-12-22 | 13G | SUNESIS PHARMACEUTICALS INC CO SNSS |
Laurence W. Lytton | 1,598,519 8.800% |
1,598,519 (New Position) |
Filing |